Literature DB >> 1746371

[Studies on the ultrastructure of the inner limiting membrane of the retina--distribution of anionic sites in the inner limiting membrane of the retina].

H Nishihara1.   

Abstract

For demonstrating ultrastructurally the distribution of anionic sites (AS) in the inner limiting membrane (ILM) of the rabbit's retina, the immersion method with cationic tracer, polyethyleneimine (PEI) was applied. This method was found to be simple and useful for the observation of AS in the ILM. In the posterior pole of the eyeball (visual streak and medullary ray), PEI particles were arranged evenly in the lamina rara (LR) of the ILM. The mean diameter of PEI particles was 20 nm, and intervals between them (40-50 nm) were the same as those of fine strands in the LR. However, the peripheral retina, the distribution of PEI particles were sparse and random, while in the lamina densa (LD) of each ILM, PEI particles were absent. AS stained with PEI were present in the residual vitreous fibers. These results may provide the morphological basis for the theory that AS of the ILM act as a charge barrier between the retina and the vitreous cavity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746371

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  11 in total

1.  Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

2.  Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheep.

Authors:  Tugba Cakmak Argun; Ozlem Yalcin Tok; Levent Tok; Gulsen Yilmaz; Fatma Meric Yilmaz; Alime Gunes; Mehmet Argun; Osman Butuner
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

3.  Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.

Authors:  Joo Young Shin; Se Joon Woo; Jeeyun Ahn; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2013-11-15

4.  Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.

Authors:  Sven Radetzky; Peter Walter; Sascha Fauser; Kan Koizumi; Bernd Kirchhof; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-23       Impact factor: 3.117

Review 5.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

6.  Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2.

Authors:  Jasmina Cehajic-Kapetanovic; Magali M Le Goff; Annette Allen; Robert J Lucas; Paul N Bishop
Journal:  Mol Vis       Date:  2011-06-30       Impact factor: 2.367

7.  Carbon nanotube electrodes for retinal implants: A study of structural and functional integration over time.

Authors:  Cyril G Eleftheriou; Jonas B Zimmermann; Henrik D Kjeldsen; Moshe David-Pur; Yael Hanein; Evelyne Sernagor
Journal:  Biomaterials       Date:  2016-10-11       Impact factor: 12.479

8.  Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes.

Authors:  Hyeong Min Kim; Seungmin Ha; Hye Kyoung Hong; Yoonha Hwang; Pilhan Kim; Eunsol Yang; Jae Yong Chung; Sunyoung Park; Young Joo Park; Kyu Hyung Park; Hyuncheol Kim; Se Joon Woo
Journal:  Transl Vis Sci Technol       Date:  2020-05-20       Impact factor: 3.283

9.  FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

10.  Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.

Authors:  Hyeong Min Kim; Hyounkoo Han; Hye Kyoung Hong; Ji Hyun Park; Kyu Hyung Park; Hyuncheol Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.